ES482869A1 - Un procedimiento para la preparacion de nuevos derivados - de pirimidona. - Google Patents

Un procedimiento para la preparacion de nuevos derivados - de pirimidona.

Info

Publication number
ES482869A1
ES482869A1 ES482869A ES482869A ES482869A1 ES 482869 A1 ES482869 A1 ES 482869A1 ES 482869 A ES482869 A ES 482869A ES 482869 A ES482869 A ES 482869A ES 482869 A1 ES482869 A1 ES 482869A1
Authority
ES
Spain
Prior art keywords
alkyl
hydroxy
alkoxy
ring
zero
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482869A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES482869A1 publication Critical patent/ES482869A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedimiento para la preparación de nuevos derivados de pirimidona de fórmula general (I): **(Fórmula)** y sales fisiológicamente aceptables, hidratos y bioprecursores de los mismos, donde R1 y R2, que pueden ser iguales o diferentes, representan cada uno de ellos hidrógeno, alquilo, cicloalquilo, alquenilo, alquinilo, aralquilo o alquilo sustituido con hidroxi, alcoxi C1-3, amino (alquil C1-3) amino o di(alquil C1-3) amino o bien R1 y R2 junto con el átomo de nitrógeno al que están enlazados forman un anillo heterocíclico alicíclico de 5 a 10 miembros que pueden estar saturado o puede contener por lo menos un doble enlace, puede estar no sustituido o puede estar sustituido con uno o más grupos alquilo C1-3 o un grupo hidroxi y/o puede contener otro heteroátomo.
ES482869A 1978-07-26 1979-07-26 Un procedimiento para la preparacion de nuevos derivados - de pirimidona. Expired ES482869A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7831153 1978-07-26

Publications (1)

Publication Number Publication Date
ES482869A1 true ES482869A1 (es) 1980-09-01

Family

ID=10498669

Family Applications (1)

Application Number Title Priority Date Filing Date
ES482869A Expired ES482869A1 (es) 1978-07-26 1979-07-26 Un procedimiento para la preparacion de nuevos derivados - de pirimidona.

Country Status (14)

Country Link
US (1) US4524071A (es)
JP (1) JPS5540670A (es)
AU (1) AU534744B2 (es)
BE (1) BE877889A (es)
CH (1) CH642952A5 (es)
DE (1) DE2928842A1 (es)
DK (1) DK310779A (es)
ES (1) ES482869A1 (es)
FR (1) FR2433527A1 (es)
GB (1) GB2030979B (es)
IT (1) IT1117778B (es)
NL (1) NL7905775A (es)
SE (1) SE7906372L (es)
ZA (1) ZA793443B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (es) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4607107A (en) * 1980-10-01 1986-08-19 Smith Kline & French Laboratories Ltd. (4-aminoalkyl-2-pyridyl alkyl)guanidines
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
US4620001A (en) * 1981-02-06 1986-10-28 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
JPS58110681A (ja) * 1981-12-23 1983-07-01 Showa Denko Kk 純鉄の錆取り方法
IT1153066B (it) * 1982-11-18 1987-01-14 Mentedison S P A Derivati del pirimidin-4-one ad attivita' erbicida
PT77623B (en) * 1982-11-25 1986-03-19 Smith Kline French Lab Process for the preparation of a small class of histamine h2-antagonists
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
GB8318638D0 (en) * 1983-07-09 1983-08-10 Smith Kline French Lab Chemical compounds
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
JO1410B1 (en) * 1984-11-03 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Vehicles
JPS61155373A (ja) * 1984-12-28 1986-07-15 Yamanouchi Pharmaceut Co Ltd 新規な２−置換アミノ−４（１ｈ）−ピリミドン誘導体及びその製造法
JPH02101170A (ja) * 1988-10-07 1990-04-12 Mitsubishi Electric Corp アルミニウム合金表面の前処理方法
JPH04323392A (ja) * 1991-04-19 1992-11-12 Nkk Corp チタン材の酸洗処理方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
IN146736B (es) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IN151188B (es) * 1978-02-13 1983-03-05 Smith Kline French Lab

Also Published As

Publication number Publication date
US4524071A (en) 1985-06-18
FR2433527B1 (es) 1982-10-15
DK310779A (da) 1980-02-29
DE2928842A1 (de) 1980-02-14
ZA793443B (en) 1980-12-31
GB2030979B (en) 1983-03-02
IT1117778B (it) 1986-02-24
BE877889A (fr) 1979-11-16
FR2433527A1 (fr) 1980-03-14
AU4924979A (en) 1980-01-31
CH642952A5 (de) 1984-05-15
JPS5540670A (en) 1980-03-22
IT7949849A0 (it) 1979-07-24
AU534744B2 (en) 1984-02-16
SE7906372L (sv) 1980-01-28
GB2030979A (en) 1980-04-16
NL7905775A (nl) 1980-01-29

Similar Documents

Publication Publication Date Title
ES482869A1 (es) Un procedimiento para la preparacion de nuevos derivados - de pirimidona.
ES476305A1 (es) Un procedimiento para la preparacion de nuevos derivados aminicos
ZA857523B (en) Pharmaceutical compositions containing diazepines and having a paf-antagonistic activity
PT628311E (pt) Derivado de xantina com actividade antidepressiva
ES8102107A1 (es) Un procedimiento para la obtencion de un derivado de tiazo- lidina
ES8101564A1 (es) Un procedimiento para la preparacion de nuevos derivados he-terociclicos
ATE62239T1 (de) Thiadiazin-derivate, sowie diese enthaltende pharmazeutische zusammensetzungen.
ATE34976T1 (de) Arylcyclobutylalkylamine und ihre verwendung als antidepressive arzneimittel.
SE7610409L (sv) Farmakologiskt aktiva foreningar
GB2023133A (en) Heterocyclic derivatives
ES8703869A1 (es) Procedimiento para preparar compuestos de 5-alaquil-1-fenil-2-piperazinoalquilpirazolin-3-ona.
ES486071A1 (es) Un procedimiento para la preparacion de derivados de amina
ES8702139A1 (es) Un procedimiento para preparar un nuevo compuesto heteroci- clico condensado con benceno
ES474155A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalquilfurano
EP0335979A4 (en) Thienopyrimidine derivatives
ES527739A0 (es) Un procedimiento para preparar derivados de pirimidina
ATE26443T1 (de) 4-aroylimidazolidin-2-one.
ATE58536T1 (de) 5-aminoalkyl-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel.
EP0982029A4 (en) PREVENTIVE / MEDICINE FOR ARTERIOSCLEROSIS
GB2014561A (en) Amine derivatives, their preparation and pharmaceutical compositions containing them
ES8602702A1 (es) Un procedimiento para la preparacion de derivados del triazol
ATE36520T1 (de) Polyprenylverbindung, ihre herstellung und pharmazeutische verwendung.
ES8204992A1 (es) Procedimiento para la obtencion de compuestos poliazahetero-ciclicos
ES8406489A1 (es) Procedimiento para la obtencion de derivados de pirano-pirazol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001204